INTRODUCTION
thio]-1H-purine) (Figure 1 ) is an immunosuppressant used in organ transplantation and autoimmune disease such as rheumatoid arthritis or inflammatory bowel disease or Crohn's disease (Anstey and Lear, 1988) . It is a safe and effective drug used alone in certain autoimmune diseases, or in combination with other immunosuppressants in organ transplantation (Oellerich et al., 1997) . Azathioprine acts to inhibit purine synthesis necessary for the proliferation of cells, especially leukocytes and lymphocytes. Azathioprine is a prodrug and more than 80% of azathioprine is converted to 6-Mercaptopurine (6-MP) (1, 7-Dihydro-6H-purine-6-thione monohydrate) (Figure 2) in the blood by the enzyme glutathione-s-transferase (GST) (Thierry and Roselyne, 1998) . Azathioprine and the metabolite 6-MP are moderately bound to serum proteins (30%). Azathioprine and 6-MP are structurally very similar, differing only in that azathioprine has a methyl-nitro-imidazolyl group attached to the sulfur atom at the 6-position of the purine ring of 6-MP (Janine and Friedman, 2002, William and Charles, 1975) . On the average, 47% of an orally administered dose of azathioprine is available to the systemic circulation. A number of analytical methods have been used to determine the azathioprine with 6-mercaptopurine. It involves mainly high performance liquid chromatography (Van Os et al., 1996, Fell and Plag, 1979) , gas chromatography (Wypior et al., 1982) and very few liquid chromatography tandem mass spectrometry methods (Hofmann et al., 2012 , Tibor et al., 2010 have been developed for the quantification in biological samples of plasma (El-Yazigi and Wahab,
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1992, Albertioni et al., 1995 , Maddocks, 1979 , Teck and Leslie, 1979 and serum (Sahnoun et al., 1990 , Torsten et al., 1996 , Tsutsumi et al., 1982 . The combination liquid chromatography/mass spectrometry is currently acknowledged as being a powerful means of determining organic molecules from complex biological matrices. The selectivity and sensitivity of LC-MS/MS has allowed for analysis times to be reduced, such that sample preparation time often exceeds the analysis time of samples. Protein precipitation, LLE (Liquid-Liquid Extraction) and SPE (Solid Phase Extraction) are the sample preparation techniques most commonly used to process plasma (Prashant et al., 2011) . Protein precipitation has the potential to be significantly less time consuming, while SPE is the technique most amenable and can also be adapted for direct injection. LLE generally provides cleaner extracts than the techniques mentioned previously, as evidenced by reduced matrix effect and less tendency for backpressure build-up in the chromatographic column as more samples are injected.
MATERIAL AND METHODS

Chemicals and reagents
Working standards of Azathioprine, Lamivudine, 6-Mercaptopurine and 6-Mercaptopurine D3 were procured from Clearsynth Labs and Vivan Life Sciences, Mumbai, India. HPLC grade Acetonitrile was purchased from JT Baker chemicals, Mumbai, India. Ammonium acetate GR grade and Ortho phosphoric acid GR grade were supplied from Merck chemicals, Mumbai, India. The solid phase extraction (SPE) cartridges of Oasis MCX (1 ml, 30 mg) were obtained by Waters (Milford, MA, sUSA). All aqueous solutions and buffers were prepared using deionized and doubly distilled water (resistivity>18 MO cm) from a Milli-Q-System obtained from In-House were used through out the experiment.
Chromatographic conditions
The LC system (SHIMADZU) (SILHTP) consists of isocratic pump (LC-20AD Prominence liquid chromatography pump), autosampler (SIL-HTc) and column thermostat. The mobile phase consists of acetonitrile: 2mM ammonium acetate (70:30 v/v) and chromatographic separation was performed at 40°C temperature with flow rate 0.800 ml/min by using ZORBAX SB CN, 75X50 mm, 5µ column.
Mass Spectrometry conditions
Mass detection was carried out on a (API 4000, AB SCIEX, USA) equipped with a source of electrospray ionization. The LC-MS/MS detector was operated at unit resolution in Multiple Reaction Monitoring (MRM) mode. The data were acquired using the Analyst 1.5 software. The transitions of molecular ions were found azathioprine-278.20/142.00, .9/119.1 and 6-MP D3-156.0/122.0.
Preparation of working standard/quality control (QC) solutions
The stock solution preparation of azathioprine and 6-MP were prepared in basified methanol at concentration of 1000 µg/mL each. The mixed calibration curve of working solutions were prepared from above stock solutions using the diluent of Methanol : Water (50:50 v/v) and ranges from 49.100 ng/mL to 2131.360 ng/mL concentrations range for azathioprine and 23.300 ng/mL to 2022.860 ng/mL concentrations range for 6-MP. The quality control samples for azathioprine were prepared at concentrations of 49.640 ng/mL (LLOQQC), 141.740 ng/mL (LQC), 506.240 ng/mL (MQC1), 843.740 
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ng/mL (MQC) and 1687.500 ng/mL (HQC) respectively using the diluents [Methanol : Water (50:50 v/v) ]. The quality control samples for 6-MP were prepared at concentrations of 23.740 ng/mL (LLOQQC), 66.800 ng/mL (LQC), 477.120 ng/mL (MQC1), 795.180 ng/mL (MQC) and 1590.360 ng/mL (HQC) respectively using diluent [Methanol : Water (50:50 v/v)]. All solution was stored at 2-8 °C and was brought to room temperature as when required. The Lamivudine and 6-MP D3 stock solutions (1 mg/ml each) were used to prepare IS mixture to achieve concentration 100000.000 ng/mL for Lamivudine and 320000.000 ng/mL for 6-Mercaptopurine D3 using diluent [Methanol : Water (50:50 v/v)]. All solution was stored at 2-8°C and was brought to room temperature as when required.
Preparation of calibration curve standards and quality control samples
The calibration curve standards and quality control samples were prepared by spiking blank plasma with above working solutions at 5% to preserve the integrity of plasma sample. The mixed calibration curve standards were prepared at concentration of 2.455 ng/mL to 106.568 ng/mL for azathioprine and 1.165 ng/mL to 101.143 ng/mL for 6-MP. The quality control samples for azathioprine were prepared at concentrations of 2.482 ng/mL (LLOQQC), 7.087 ng/mL (LQC), 25.312 ng/mL (MQC1), 42.187 ng/mL (MQC) and 84.375 ng/mL (HQC) respectively using the diluent [Methanol : Water (50:50 v/v)]. The quality control samples for 6-MP were prepared at concentrations of 1.187 ng/mL (LLOQQC), 3.340 ng/mL (LQC), 23.856 ng/mL (MQC1), 39.759 ng/mL (MQC) and 79.518 ng/mL (HQC) respectively using diluent [Methanol : Water (50:50 v/v) ]. All aliquots of spiked plasma were transferred to RIA tube and stored at below -70±5°C.
Sample Preparation and Extraction
Aliquot 500 µL of spiked Plasma sample in RIA tube, add 50 µL (6-Mercaptopurine Labeled (6MP-D3) + Lamivudine), internal standard solution (Except calibration blank) and vortex it for 10 seconds. Add 500 µL of 2% O-Phosphoric acid and vortex for 30 seconds. Condition Oasis MCX cartridges with 1.0 mL of methanol and equilibrate with 1.0 mL of 2% O-Phosphoric acid, load the sample in SPE manifold and wash SPE cartridges with 1.0 mL of 2% OPhosphoric acid and1.0 mL of acidified Methanol (pH: 2.3). Elute the cartridges with 2.0 mL of 5% ammonia in methanol and evaporate the sample at 
RESULTS AND DISCUSSION
The method here in presented is specific SPEEvaporation protocol allowed a rapid method for the simultaneous extraction of azathioprine and 6-MP to be developed, since a large number of samples can be determined daily by using this approach (Dervieux and Boulieu, 1998, Kato et al., 1991) . As for the extraction itself, the selected method proved to be very simple and reproducible. The Solid Phase Extraction (SPE) procedure with Oasis MCX cartridges provided cleaner samples and good recovery (Angela et al., 2008) . The addition of 2% O-Phosphoric acid enhances the analyte interest retention other than plasma elements in SPE cartridges that influences the matrix effect (Matrinez et al., 2003 , Petrovic et al., 2002 . The addition of 2% O-Phosphoric acid and acidified methanol (pH-2.3) washing solution at washing step, decreased the presence of plasma elements upto >80%, when compared with the use of pure water washing twice (Miao et al., 2002, Hilton and Thomas, 2003) . However, even with this improvement, the final evaporation method for eluent aids further cleaner sample and improved sensitivity. The co-elution of plasma elements produced (despite the MRM) unexpected peaks when short C8 and C18 columns (50 mm) were applied. The use of ZORBAX SB CN column, 75X50 mm, 5 µ increased the run time (3.0 min) but decreased the intensities of the peaks attributed to plasma elements. Furthermore, these peaks didn't appear in the respective retention times of azathioprine and 6-MP ( Figure. 03, 04, 06 and 07). The S/N ratio was found to be >5 for azathioprine and 6-MP in the lower standard sample, which was set to be the LOQ, Since these peaks were determined using normal blank plasma, further experiments with hemolyzed and lipemic blank plasma were also performed, but the yield chromatograms for these did not exhibit any real differences from those for normal blank plasma ( Figure. 05 & 08). Judging from our experience, there are very few hemolyzed and lipemic samples present among the hundreds obtained from a bioequivalence study. Therefore, the samples obtained from such studies are expected to show the same behavior with the spiked plasma samples produced during the pre-study validation. After the completion of the pre-study validation, the ESI source was quite clean, which is of great significance for SPE extraction protocols and evaporation. Therefore, it might be necessary to clean the source in the middle of a bioequivalence study (usually>1000 samples), especially if the signal intensity has decreased. We intend to provide studies dealing with the interference obtained from plasma elements in ESI when following an SPE-Evaporation 
protocol in an upcoming report. The retention times of all compounds and the column backpressure remained practically constant by the end of prestudy validation.
Method Validation
The complete validation was performed according to the guidelines of US Food and Drug Administration (USFDA) on bioanalytical method validation (Guidance for Industry, 2003, Guidance for Bioavailability and Bioequivalence Studies, 2005, Guidance for Industry, 2001, Chow and Liu, 1999) .
Linearity
Linearity was used to confine the performance of the method. A linear least squares regression with a three calibration curves were prepared using eight non-zero standards ranging from 2.455 ng/mL to 106.568 ng/mL for azathioprine and 1.165 ng/mL to 101.143 ng/mL for 6-MP for each analytical run. Peak area ratios of each drug to IS were used for regression analysis. A linear regression model (y=mx+c) was evaluated, using 1/X 2 as weighting factor, where X is the concentration of each drug and y corresponds to the areas ratio. The regression coefficients (r 2 ) for the three runs were greater than 0.98 for azathioprine and 6-MP. The standard curves obtained for the two molecules are presented in Table 1 and 2, respectively. Consequently, SPEEvaporation procedure applied in this method was able to produce satisfactory concentration data for azathioprine and 6-MP standard samples.
Sensitivity
The limit of detection (LOD) and the limit of quantification (LOQ) were performed by measuring the analytical background response. The individual standard curve data from three runs met all of the preset criteria: i) <20% deviation from the nominal concentration at the limit of quantification (LOQ), which was defined as the lowest standard, ii) <15% deviation of standards from their back calculated concentration, other than LOQ from nominal concentrations, iii) at least six out of eight nonzero 
Accuracy and precision
The precision and accuracy were also assessed by analyzing method validation samples over three runs. The percentage accuracy was determined by calculating the deviations of the predicted concentrations from their nominal values. The intra-assay precision was assessed by analyzing six replicates at each QC level, while the inter-assay precision was determined over three runs conducted on two days by analyzing 30 samples. Data for both types of accuracy and precision (expressed as CV %) are presented in Tables 3, 4 and 5 azathioprine and 6-MP respectively. These results, as well as the respective values for the percentage accuracy were within the acceptance criteria.
Stability studies
The stability quality control plasma samples LQC-7.087 ng/mL and HQC-84.375 ng/mL for azathioprine and LQC-3.340 ng/mL and HQC-79.518 ng/mL for 6-MP (Table 6 ). To evaluate the freeze-thaw stability, a freeze-and-thaw cycle was defined as the storage of LQC and HQC samples at -80°C, followed by thawing at room temperature. Samples were analyzed after the fifth cycle, along with fresh reference samples of the same concentration. Back-calculated concentrations of fifth freeze-thaw cycles versus fresh were within the acceptance limit (<10% variation).
To evaluate the Bench top stability, six aliquots of LQC and HQC were maintained at room temperatures for 23 Hrs 23 Min without processing (which exceeds the time that samples normally remain at room temperature). After a stipulated period of storage over bench, stability samples were processed and analyzed against fresh CC and fresh QC.
To check long-term stability, aliquots of the two sample types were initially frozen at -70°C for 30 days, and then thawed and analyzed. The 30 day period is more than adequate for the analysis of samples from a bioequivalence study, since the current method allows the measurement of more number of samples per day. All of the molecules were stable (<10% variation) under these conditions. Stock solution stability was estimated by comparing fresh and old dilutions in mobile phase of these solutions (stored at 4°C). The measurements proved that the concentrations of azathioprine and 6-MP in stock solution remained intact (variation <5%).
Autosampler stability was another part of the method validation that was tested. This was assessed by comparing QC samples included at the beginning, at half-way and upon completion of each of the three analytical runs. The stabilities of all molecules in the autosampler (5°C) were acceptable.
Recovery Studies
The recovery of the proposed method, were spiked with different concentrations of azathioprine and 6-MP. The recovery was obtained by performing the mean response of each concentration and dividing with the extracted sample mean by the unextracted (spiked blank plasma extract) sample mean of the actual concentration (Table 7) . The difference between the unextracted samples, spiked plasma residues and the extracted sample was done in order to minimize the matrix effects, giving a true recovery. The recoveries observed for azathioprine and mercaptopurine was 99.36% and 6-MP was 100.44%.
CONCLUSION
A SPE-Evaporation protocol described above was developed for the simultaneous quantification of Azathioprine and 6-Mercaptopurine in human plasma. Azathioprine is a prodrug, which convert into active metabolite 6-Mercaptopurine in the blood after it has been administered. The current method includes, for the first time, a single sample preparation procedure and a rapid LC-MS/MS protocol. Therefore, more number of samples can be analyzed daily, while only small quantities of plasma and solvent are consumed. The method developed here was validated over the concentration 2.455 ng/mL to 106.568 ng/mL for azathioprine 
